Product
Supplier
Encyclopedia
Inquiry
Home > News > Blog > Doctors' Scientific Study Of Chronic Fatigue After Virus

Doctors' Scientific Study Of Chronic Fatigue After Virus

ECHEMI 2022-05-17

Abstract


Patients are very likely to develop chronic fatigue after virus infection. Here we take the COVID-19 as an example to briefly explain the relationship between the COVID-19 and chronic fatigue. While various symptoms of new coronary pneumonia gradually surfaced, scientists also found that after some new coronavirus infected people recovered, their bodies did not return to their previous state, but suffered from long-term fatigue, pain, palpitations, and confusion. Chronic fatigue after viral infections can persist for weeks or even months. Therefore, doctors from various countries began to study the possible link between COVID-19 and chronic fatigue syndrome.

 

According to abs reports, many people can now recognize the symptoms of new coronary pneumonia: fever, fatigue, shortness of breath, but few people know that these symptoms will recur after recovery, and are very similar to another disease - chronic fatigue syndrome . Chronic fatigue syndrome is a medical condition that usually occurs after a viral infection and causes fever, pain and prolonged tiredness, as well as depression. Many COVID-19 patients, and some who were never hospitalized, reported persistent symptoms after they recovered from their initial COVID-19 diagnosis. Although very little is known about CFS, the CDC says as many as 2.5 million Americans may have CFS. Before the new crown epidemic, scientists and doctors were already studying the relationship between chronic fatigue syndrome and the human herpes virus, and said that chronic fatigue after virus can last for a long time. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, also pointed out that these sequelae will make many young people suffer. They often experience persistent fatigue, joint pain, headaches, sleep problems, and reduced concentration and memory, which can lead to a significant decrease in mobility and stress resistance.

 

According to the report, Dr Mark VanNess of the University of the Pacific estimated: "Around 75 to 80 percent of chronic fatigue syndrome is a post-viral syndrome, in which viral infection and the ensuing immune response are responsible for long-term symptoms. Incentives." Now it appears that some patients with new coronary pneumonia have symptoms similar to those of chronic fatigue syndrome patients after contracting the virus. This observation has prompted some doctors to start exploring whether there is a link between the two conditions. According to a July 2020 report from the U.S. Centers for Disease Control and Prevention, the exact extent and speed of recovery of patients with new coronary pneumonia is not fully understood, and up to 25% of people with the new coronavirus feel "not like their normal selves" two to three weeks after testing positive. It's unclear why some patients continue to experience persistent fatigue after recovering from COVID-19, and doctors don't know if a significant percentage of these patients develop chronic fatigue syndrome. But if a person with COVID-19 still feels fatigued after six months of recovery, they should seek medical attention as soon as possible.

 

The study, led by scholars from Karolinska Institutet and Danderyd Danderyd Hospital in Sweden, looked at changes in immunity after COVID-19 infection through community research. The results showed that 26% of people infected with the new crown developed at least one symptom of moderate to severe fatigue that lasted for more than two months, compared with 9% of those who were negative for antibodies.

 

Matt Hancock, the UK's health secretary, told the BBC on 5 July 2020 that the problem was incalculable. "It's a serious problem for the small percentage of people who have been infected with Covid-19," Hancock said. Covid-19 has left a long-term effect in some people and it feels like post viral fatigue syndrome.


Summary


As the global epidemic curve slows, the focus of anti-epidemic work has gradually shifted. The emergence of patients with COVID-19 sequelae is not only a scientific research challenge, but also a policy planning challenge. At present, the research on chronic fatigue after virus infection is still in the stage of interview investigation and data collection, and many data and theories are based on the promotion of previous coronavirus research. Therefore, the particularity of the new coronavirus requires more pathological and clinical research. Only by understanding the specific ways in which the new coronavirus affects the human body in the long term can a more effective treatment plan be proposed as soon as possible. In terms of policies, developed countries are currently paying certain attention to the problem of sequelae, but they still need to further implement assistance to patients by strengthening legislation and other measures; while many developing countries need the help of international organizations such as WHO and various forces. Improve relevant measures as soon as possible to maintain national health in the post-epidemic era.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.